QUOIN PHARMACEUTICALS LTD
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$4.54
+9.40%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-3.8%
3 months
+2.0%
6 months
-26.9%
1 year
-60.3%
Year to date
-68.5%
52-week range
$3.25 – $22.30
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$16M
P/E
-0.9
P/B
4.1
P/S
—
Revenue
$0
Net income
-$18.67M
Diluted EPS
—
Gross margin
—
Net margin
—
Return on equity
-303.40%
Total debt
$0
Cash
$3.85M
Free cash flow
-$15.27M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$5.37M | — | — | -$3.14M |
| Mar 31, 2026 | $0 | -$5M | — | — | -$4.87M |
| Dec 31, 2025 | $0 | -$4.35M | — | — | -$5.04M |
| Sep 30, 2025 | $0 | -$3.95M | — | — | -$2.23M |
| Jun 30, 2025 | $0 | -$3.7M | — | — | -$3.69M |
| Mar 31, 2025 | $0 | -$3.81M | — | — | -$2.59M |
| Dec 31, 2024 | $0 | -$2.31M | — | — | -$2.24M |
| Sep 30, 2024 | $0 | -$2.35M | — | — | -$2.18M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent QNRX news
All market newsNo ticker-linked stories are in the current archive.